$17.99
-1.01-5.32%
Pre-Market: 4:41 AM EDT
Comments
Loading...
Monopar Therapeutics (NASDAQ:MNPR) Stock, Insider Trading Activity
Monopar Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Monopar Therapeutics Inc Insiders Doing?
At Monopar Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 1.55K shares for a total value of $25.19K.
Notable Recent Insider Buys and Sales
- On October 30, 2024, Karthik Radhakrishnan, the company's CHIEF FINANCIAL OFFICER purchased 1.55K shares for $16.25 each.
Ownership Statistics for Monopar Therapeutics Inc
Shares Outstanding
5.278M
Insider Shares Owned
515.019K
Insider Percentage Owned
14.6%
Institutional Shares Held
17.840K
Institutional Percentage Held
0.31%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.